Start date: 01 April 2020
End date: 31 March 2025
The CARE consortium is a coalition of 37 academic institutions, pharmaceutical companies and non-profit research organizations whose main objectives are the development of therapeutics (i) to provide an emergency response towards the current COVID-19 pandemic by drug repositioning and (ii) to address the current and/or future coronavirus outbreaks by broad-spectrum small-molecule drug discovery and/or virus-neutralizing antibody discovery. Lead candidates will be advanced into Phase1 and Phase 2 clinical trials in humans.
Scientific coordinator of the project: Yves Levy